Galantamine in Alzheimer's disease.
Galantamine is a cholinesterase inhibitor with a dual mechanism of action. It is a reversible inhibitor of acetylcholine esterase and enhances the intrinsic action of acetylcholine on nicotinic receptors, leading to increased cholinergic neurotransmission in the CNS. Galantamine has a large volume c...
Váldodahkkit: | Razay, G, Wilcock, G |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2008
|
Geahča maid
-
The beneficial effects of galantamine on caregiver time in Alzheimer's disease
Dahkki: Sano, M, et al.
Almmustuhtton: (2003) -
The effects of galantamine treatment on caregiver time in Alzheimer's disease.
Dahkki: Sano, M, et al.
Almmustuhtton: (2003) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (2000) -
Hyperinsulinaemia and Alzheimer's disease.
Dahkki: Razay, G, et al.
Almmustuhtton: (1994) -
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (2003)